Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 11 Estimated RRs for use of HTPs for individual studies and biomarkers and combined

From: Estimating lung cancer risk from e-cigarettes and heated tobacco products: applications of a tool based on biomarkers of exposure and of potential harm

Biomarker

    

Class

Group

Marker

Study

RR (95% CI)

BOE

Acrylonitrile

HEMA

Scherer et al. (2023) [21]

1.07 (0.73–1.59)

 

Anabasine

NAB

Scherer et al. (2022) [19]

2.49 (1.39–4.47)

 

Anatabine

NAT

Scherer et al. (2022) [19]

3.49 (1.98–6.13)

 

Phenanthrene

4-OH-Phe

Scherer et al. (2022) [20]

0.43 (0.22–0.86)

All

 

All

 

1.44 (0.41–5.08)

Back to article page

Harm Reduction Journal

ISSN: 1477-7517